Clinical Trials Logo

Sleep Architecture clinical trials

View clinical trials related to Sleep Architecture.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06221124 Completed - Clinical trials for Sleep-Disordered Breathing

Ring-type Pulse Oximeter for Evaluation for Sleep Assessment Study

ROSA
Start date: July 15, 2020
Phase: N/A
Study type: Interventional

Recently, various electronic lifestyle activity monitoring devices (ELAM) are increasingly commercially available. However, the quality and reliability of the data from ELAM are unclear, compared with polysomnography (PSG), which is the gold-standard sleep assessment method. Thus, combining ELAM with PSG will validate ELAM and improve its clinical and research utilization. The investigators propose to conduct this study to validate ELAM device for sleep assessment. The investigators will compare Belun Ring data collection and overnight in-lab PSG measures of Sleep-Disordered Breathing (SDB) and sleep architecture in adults with obstructive sleep apnea (OSA) symptoms. The investigators propose to recruit a total of 40 participants with symptoms of OSA. The overall accuracy, sensitivity and specificity of Belun Ring to assess SDB and sleep architecture will be validated by using PSG analysis as a gold standard.

NCT ID: NCT05591573 Completed - Cognitive Function Clinical Trials

The Impact of Glycemic Index on Sleep and Memory Consolidation

Start date: December 31, 2022
Phase: N/A
Study type: Interventional

The study will test whether the consumption of a low versus a high glycemic index pre-bed drink influences sleep architecture, memory consolidation, nocturnal glucose metabolism, and mood.

NCT ID: NCT01650454 Completed - Clinical trials for Cognitive Impairment

Sleep, Cognition and Memory Disorder

SCOAL
Start date: January 2013
Phase: N/A
Study type: Interventional

The increasing incidence of Alzheimer's disease (AD) and related sleep-disorders with the aging of the population is a major issue of public health. The prevalence of sleep disturbances is about 50% in dementia patients. Sleep in dementia is mainly characterized by prolonged night-time awakenings, sometimes with longer sleep latency and/or early awakening. The presence of these sleep disturbances is the main reason for the institutionalization of AD patients, as well as a major cause of the deterioration of the caregivers' sleep. The MEMENTO cohort is composed of patients with isolated memory complaints or mild cognitive impairment, at high risk to develop dementia. All voluntary patients from the CMRR (Center of Memory, resources and Research) of Bordeaux (MEMENTO cohort) will be tested at inclusion and followed-up 1 year later. For these two evaluations, actigraphic monitoring at home, 2-night polysomnography (PSG) monitoring at hospital including a 24-hour period of urinary melatonin dosage, neuropsychological tests battery, a virtual reality tool and questionnaires will be used.